Study of the Correlation between Brain natriuretic peptide and Each of Malondialdehyde, Ceruloplasmin and Transferrin in patients with Heart failure(HF) in Thi-Qar Governorate
Keywords:
Heart failure, Brain natriuretic peptide, Malondialdehyde, ceruloplasmin, transferrinAbstract
Objective: Heart failure is a chronic condition where the heart is unable to provide the different organs with adequate circulation of blood due to abnormality in the heart and changes in the hemodynamic, kidney, nerve and hormone system. The present study is designed to determine the levels of Brain natriuretic peptide (BNP), Malondialdehyde (MDA), Ceruloplasmin (Cp) and transferring (Tf) in patients with systolic Heart failure (HF) with Hypertension and healthy individuals. Subjects: Serum Brain natriuretic peptide, malondialdehyde, ceruloplasmin and transferrin were measured in 68 patients heart failure and 68 supposedhealthy subjects . Results:The levels of serum Brain natriuretic peptide, malondialdehyde and ceruloplasmin were revealed significant increase in patients with heart failure as compared to control group whereas the levels transferrin showed a significant decrease in heart failure patients in comparison to control subjects(P ≤0.05).This study was also revealed the correlation between the concentrations of the measured parameters and BNP. Conclusion:This study revealed significant increase BNP in patients with (HF) and Serum BNP may have a significant diagnostic role in heart failure.Lipid peroxidation and oxidative stress is more prominent in patients with (HF) comparison to healthy individuals , and there is a disorder in antioxidant system in patient with heart failure .according to the levels of ceruloplasmin and transferringReferences
Abraham ,W.T. , Compton, S. , Haas, G. , et al. (2011). Intrathoracic impedance vs daily weight monitoring for predicting worsening heart failure events: results of the Fluid Accumulation Status Trial (FAST). Congest Heart Fail. 17:51-5 .
Aisen, P. (1984). Semin. Liver Dis. 4:193-206.
Badgett, R.G. , Mulrow, C.D. , Otto, P.M. et al. (1996). How well can the chest radiograph diagnose left ventricular dysfunction? Journal of General Internal Medicine.11(10):625-634.
Bowman, B.H. , Yana. F. , and Adrian, G. S. (1988). in Advances in Genetics (Caspari, E. W:, and Scandalios, J. G., eds) . 25: l-38, Academic Press, New York.
Burtis C.A. , E.R. Ashwood, and W.B. Saunders (1999). tietz N.W. Text book of clinical chemistry, 3rd Ed. P: 1699-1703.
Burtis, C.A. ,and Ashwood, E.R.(1996). Tetiz Fundamentals of Clinical Chemistry, 4th edn. Eds. W.B. Saunders company.Phladelphia. p: 272, 274, 275, 376,727.
Caimi, G. , Carollo, C. , and Lo Presti, R. (2003). Diabetes Mellitus: Oxidative Stress and Wine. Curr Med Res Opin .19(7):581–6.
Cavalca, V. , Cighetti, G. , Bamonti, F. , et al. (2001). Oxidative stress and homocysteine in coronary artery disease. Clin Chem. 47:88-92.
Cheng, V. , Kazanagra, R. , Garcia, A. , et al. (2001). B-type peptide predicts treatment outcomes in patients admitted for decompensated heart failure: a pilot study. J Am Coll Cardil . 37: 386-91.
Choi, S.L. ,Kwon, O.B. , Eum, W.S. , and Kang, J.H.(2000). Fragmentation of human ceruloplasmin induced by hydrogen peroxide. Biochem. 82:175-180.
Chrysohoou, C. , Pitsavos, C. , Aggelopoulos, P. , et al. (2010). Brain natriuretic peptide mediates the effect of creatinine clearance on development of left ventricular systolic dysfunction in patients with acute coronary syndrome. Hellenic J Cardiol. 51: 413-420.
Clerico, A. , Del, R.y. S. , Maffei, S. , Prontera, C. , Emdin, M. , Giannessi, D. (2002). The circulating levels of cardiac natriuretic hormones in healthy adults: effects of age and sex. Clin Chem Lab Med. 40:371-7.
Cowie MR, Mendez GF.(2002). BNP and congestive heart failure. Prog Cardiovasc Dis.44;293-321.
Cowie, M.R. , Struthers, A.D. , Wood, D.A. , Coats, A.J. , Thompson, S.G. , Poole-Wilson, P.A. , Sutton, G.C. (1997). Value of natriuretic peptides in assessment of patients with possible new heart failure in primary care. Lancet. 350:1349-53.
Curzon, G. (1961). Some properties of coupled iron-ceruloplasmin oxidation systems. Biochem. J. 79:656-663.
Fleming, R.E. , Whitman, I.P. , and Gittin, J.D. (1991). Induction of ceruloplasmin gene expression in rat lung during inflammation and hypoxia. Am. J. Physiol. 266: L68-L74.
Fong, K.L. , McCay, P.B. , and Poyer, J.L. (1973). J. Biol. Chem. 248:7792.17
Fox, P.L. , Mazumder, B. , Ehrenwald, E. , Mukhopadhyay, C.K .(2000). Ceruloplasmin and cardiovascular disease. Free Radic Biol Med .28:1735-44.
Gambino R, Desvarieux E, Orth M, Matan H, Ackattupathil T, Lijoi E, et al. (1997) . The relationship between chemically measured total iron-binding capacity con-centrations and immunologically measured transferrin concentrations in human serum. Clin Chem 1997;43:2408–12.
Giannakoulas, G. , Dimopoulos, K. , Bolger, A.P. , et al. (2010). Usefulness of natriuretic peptide levels to predict mortality in adults with congenital heart disease. Am Journal Cardiol. 105: 869-873.
Guyatt, G.H. , Oxman, A.D. , and Ali, M. (1992). Laboratory diagnosis of iron-deficiency anemia: an overview. J Gen Intern Med. 7:145-153.
Hobbs, F.D. , Davis, R.C. , Roalfe, A.K. , et al. (2002). Reliability of N-terminal pro-brain natriuretic peptide assay in diagnosis of heart failure: cohort study in representative and high risk community populations. BMJ. Jun 22. 324(7352):1498.
Jayakumari, N. , Ambikakumari, V. , Balakrishnan, K.G. , Iyer, B.K. (1992). Antioxidant status in relation to free radical production during stable and unstable angina syndromes. Atherosclerosis . 94:183-90.
Jenkinson, A. , Franklin, M. F. , Wahle, K. , and Duthie, G. G. (1999). Dietary intakes of polyunsaturated fatty acids and indices of oxidative stress in human volunteers. 53: 523-528.
Kang, J.H. (2006). Oxidative modification of human ceruloplasmin by methylglyoxal: An invitro study. J. Bioch. Mol. Biol. 39 (3): 335-338.
Kober, L. , Torp-Pedersen, C. , McMurray, J.J. , et al. (2008). Increased mortality after dronedarone therapy for severe heart failure. N Engl J Med. 358:2678-87 . 27.Koch, A. , Zink, S. , Singer, H. (2006). B-type natriuretic peptide in paediatric patients with congenital heart disease. Eur Heart J. 27: 861-866.
Koglin, J. , Pehlivanli, S. , Schwaiblmair, M. ,Vogeser, M. , Cremer, P. , vonSc-heidt , W. (2001). Role of brain natriuretic peptide in risk stratification of patients with congestive heart failure. J Am Coll Cardiol. 38:1934–1941.
La Monte, M. J. , Eisenman, P. A. , Adams, T. D. ,Shultz, B. B. , Ainsworth, B. E. , and Yanowitz, F. G. (2000). Cardiorespiratory fitness and coronary heart disease risk
factors: The LDS Hospital Fitness Institute Cohort. Circulation. 102(14):1623-1628. 30.Levin, E.R. ,Gardner, D.G. ,Samson, W.K. (1998). Natriuretic peptides. N Engl J Med. 339:321–328 .
Lloyd-Jones, D. , Adams, R.J. , Brown, T.M. , et al. (2010). Heart disease and stroke statistics--2010 update: a report from the American Heart Association. Circulation. 121:e46-e215.
Maeda, K. ,Tsutamoto, T. , Wada, A. , Hisanaga, T. , Kinoshita, M. (1998). Plasmabrain natriuretic peptide as a biochemical marker of high left ventricularend-diastolic pressure in patients with symptomatic left ventriculardysfunction. Am Heart J. 135:825–832 .
Maisel, A.S. (2003). Use of BNP levels in monitoring hospitalized heart failure patients with heart failure.Heart Fail Rev. 8:339–344.
Maisel, A.S. , Krishnaswamy, P. ,Nowak, R.M. , McCord, J. , Hollander, J.E. , Duc, P. , Omland, T. , Storrow, A.B. , Abraham, W.T. , Wu, A.H. , Clopton ,P. , Steg, P.G. , Westheim, A. , Knudsen, C.W. , Perez ,A. , Kazanegra, R. , Herrmann, H.C. ,McCullough, P.A. (2002). Breathing Not Properly Multinational Study Investigators. Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure. N Engl J Med. 347:161-7.
McMurray, J.J., Adamopoulos, S., Anker, S.D. ,et al . (2012). ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure of the European Society of Cardiology Developed in collaboration with the Heart Failure Association (HFA) of the ESC. Eur J Heart Fail. 14(8) ; 803-69
Menden, C.E. , Boian, J.M. , Murthy, L. , and Petering, H.G.(1977).Anal Lett., 10: 197 .
Morgan, E. H. (1983). Plasma Protein Secretion by the Liver (Glaumann, H., Peters, T., Jr., and Redman, C., eds) .Academic Press, New York . pp: 331-355.
Moser D.K., Dickson, V., Jaarsma, T., Lee,C., Stromberg, A. and Riegel B. (2012). Role of self-care in the patient with heart failure. Curr Cardiol Rep . 14(3); 75-265.
Nuttall, S.L. , Dunne, F. , Kendall, M.J. , and Martin, U. (1999). Age independent oxidative stress in elderly patients with NIDDM. QJ Med .92:33–8.
Panou, F.K. , Kotseroglou, V.K. , Lakoumentas, J.A. , et al. (2006). Significance of brain natriuretic peptide in the evaluation of symptoms and the degree of left ventricular diastolic dysfunction in patients with hypertrophic cardiomyopathy. Hellenic J Cardiol. 47: 344-351.
Parcharidis, G. (2011). Adult congenital heart disease in Greece: need for a step forward. Hellenic J Cardiol. 52: 193-194.
Pushpa B, Chandra M, and Misra WK.(2005). Oxidative stress parameters in erythocytes of post-reperfused patients with infarction. J Enz Inhib Med Chem.; 20: 377-81.
Rajesh, K.G. ,Surekha, R. H. , Mrudula, S. K. , Prasad, Y. , Sanjib, K. S. , Prathiba, N. (2011). Oxidative and nitrosative stress in association with DNA damage in coronary heart disease. Singapore MedJ.52:283-8.
Richards, A.M. , Nicholls, M.G. , Yandle, T.G. , Frampton, C. , Espiner, E.A. , Turner, J.G. ,Buttimore ,R.C. , Lainchbury, J.G. , Elliott, J.M. , Ikram, H. , Crozier, I. G. , Smyth, D.W. (1998). Plasma N-terminal pro-brain natriuretic peptide and adrenomedullin: new neurohormonal predictors of left ventricular function and prognosis after myocardial infarction. Circulation. 97:1921-9.
Sirajwala, H.B. , Dabhi, A.S. , Malukar, N.R. , Bhalgami, R. B. ,and Pandya, T. P. (2007). Serum ceruloplasmin level as an extracellular antioxidant in acute myocardial infarction. J. Indin Academy of Clin. Med. 8 (2): 135-8.
Takahashi, N. , Ortel, T.L. , and Putnam, F.W. (1984). Single chain structure of human ceruloplasmin. The complete amino acid sequence of the whole molecule. Proc. Natl. Acad. Sci. USA . 81:390-4.
Tang, W. H. (2007). B-type natriuretic peptide: a critical review. Congestive heart failure (Greenwich, Conn). 13 (1): 48-52.
Tsutamoto, T. ,Wada, A. ,Maeda, K. , et al. (1997). Attenuation of compensation of endogenous cardiac natriuretic peptide system in chronic heart failure: prognostic role of plasma brain natriuretic peptide concentration inpatients with chronic symptomatic left ventricular dysfunction.Circu-lation. 96:509–516 .
van der Wal, M.H., Jaarsma, T. & van Veldhuisen, D.J. (2005). Non-compliance in patients with heart failure; how can we manage it . Eur J Heart Fail 7(1) ; 17-5.
Vostreis. M.. Moran. P. L.. and Seliaman. P. A.(1988). ,J. Clin. Invest. 82,331~339; 1988.
